Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
146.00
-1.04 (-0.71%)
At close: Jan 12, 2026
184.32%
Market Cap3.32B
Revenue (ttm)1.61B
Net Income (ttm)517.39M
Shares Out22.75M
EPS (ttm)22.74
PE Ratio6.42
Forward PEn/a
Dividend13.19 (9.03%)
Ex-Dividend DateOct 27, 2025
Volume435,212
Average Volume391,097
Open147.04
Previous Close147.04
Day's Range145.76 - 149.50
52-Week Range47.15 - 232.95
Beta0.20
RSI27.77
Earnings DateFeb 9, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements

News

There is no news available yet.